Orthopedia Stock Price, News & Analysis

OrthoPediatrics Corp. (KIDS) is set to release its fourth quarter and full year 2021 financial results on March 2, 2022, following market close. The company will host a conference call on March 3, 2022, at 8:00 a.m. ET to discuss the results, accessible via dial-in for both domestic and international callers and through a live webcast on its investor relations page. OrthoPediatrics specializes in pediatric orthopedics, offering 37 surgical systems across key categories including trauma, scoliosis, and sports medicine, with distribution extending to 45 countries.

OrthoPediatrics Corp. (Nasdaq: KIDS) announced preliminary unaudited revenue for Q4 and full year 2021. Q4 revenue is estimated at $24.8 million, a 31% increase from Q4 2020's $18.9 million. Domestic revenue rose 11%, while international revenue surged 363%. Full year 2021 revenue is expected to reach $98.0 million, reflecting 38% growth. Domestic sales grew 24%, and international sales increased 150%. The final financial results will be released in March 2022, as these figures are subject to audit adjustments.

Telos Partners LLC, a subsidiary of OrthoPediatrics Corporation (NASDAQ: KIDS), has appointed Scott Day as Senior VP and General Manager. This follows the leadership of Jason Inzana, who established a strong foundation for predictable revenue. Since the acquisition, Telos has doubled its team and expanded its client base, positioning itself for growth amid industry challenges. Day, with a successful track record in medical technology, aims to lead Telos through an aggressive growth phase while ensuring high-quality outcomes for clients.

OrthoPediatrics Corp. (NASDAQ: KIDS) recently reaffirmed its commitment as a Double-Diamond sponsor of the International Pediatric Orthopaedic Symposium (IPOS) held from December 7 to 11 in Orlando, Florida, attracting over 400 pediatric orthopedic surgeons. CEO David Bailey emphasized the value of in-person connections and the company's enduring partnership with the Pediatric Orthopedic Society of North America (POSNA). Furthermore, OrthoPediatrics showcased its expanding portfolio, including exclusive technologies like ApiFix and 7D Flash Intraoperative Navigation, aimed at enhancing pediatric orthopedic practices.

OrthoPediatrics Corp (Nasdaq: KIDS) announced its participation in the 33rd Annual Piper Sandler Virtual Healthcare Conference with a fireside chat webcast featuring CEO Dave Bailey and COO Fred Hite. This event will include 1x1 investor meetings scheduled for December 1, 2021, accessible exclusively through Piper Sandler. Additionally, the audio webcast will be available on OrthoPediatrics' investor relations website until December 2, 2021. OrthoPediatrics specializes in pediatric orthopedics, offering 36 surgical systems to enhance care for children with orthopedic conditions.

OrthoPediatrics Corp. (KIDS) reported a third quarter 2021 revenue of $25.1 million, a 13% increase from $22.2 million in Q3 2020. Domestic revenue fell 1% to $19.4 million, while international revenue surged 118% to $5.7 million. Trauma and Deformity revenue was up 12%, Scoliosis revenue grew 11%, and Sports Medicine/Other revenue rose 46%. The company maintained its full-year revenue guidance of $97-$101 million, projecting 36% to 42% growth over 2020. Net loss narrowed to $2.2 million from $4.5 million year-on-year.

OrthoPediatrics Corp (Nasdaq: KIDS) will have key executives participating in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on November 15, 2021, at 10:00 AM ET. The executives include President & CEO Dave Bailey, COO and CFO Fred Hite, and Executive Chairman Mark Throdahl. The event will feature a webcast format and include one-on-one meetings. An audio replay of the presentation will be made available for 90 days on the company's investor relations website, showcasing their dedicated focus on pediatric orthopedic advancements.

OrthoPediatrics Corp. (KIDS) has received a Silver metal designation in the "COVID Stops Here" campaign for achieving an 80%+ vaccination rate at its Indiana headquarters. This recognition highlights the importance of widespread vaccinations in combatting COVID-19, particularly the Delta variant. OrthoPediatrics' President emphasized the company's commitment to the health and safety of its employees throughout the pandemic. The campaign, promoted by the Indiana Chamber of Commerce, aims to encourage more organizations to prioritize COVID-19 vaccinations.